General
DDW Service Planning and Budgets for Adults: Clinical Review & Clinical/Service Criteria
February 2022 HAN Alerts
Guidance for immunocompromised - 02-15-2022 , COVID Therapeutics - Quick Reference for Prescribers - 02-16-2022, COVID-19 Therapeutics Update: Patient Eligibility Criteria & New COVID-19 Therapeutic - 02-16-2022, COVID -19 Dealth Risk Increases as the Number of Comorbid Conditions Increases - 02-16-2022, COVID -19 Dealth Risk for Select Age Groups and Comorbid Conditions - 02-16-2022, Update for Providers regarding COVID-19 & Immunocompromised Patients - 02-22-2022, COVID-19 Therapeutics Update: Evusheld - 02-28-2022.CESP or Acre Training Requirements Compliance Extension
Revisions to Comprehensive Risk Management Plan Document
Statewide Aspiration Risk List (SARL) transition to Smartsheet
Telehealth-Technology ISP Addendum
This is a list of provider names.
DDW Standards Chapter 22.4: Annual Reports; Supports Waiver Standards
Current Advisory Council Members List
Naloxone Standing Order for Opioid Treatment Centers/Programs
Notice of Minor, Nonsubstantive Correction 7.1.32
This memo was released by the emergency medical services commission to address licensed emergency medical services personnel who have been convicted of driving under the influence and sentenced to having an ignition interlock device installed on their personal vehicles as part of their rehabilitation.
Time Reconciliation between EVV and Service-Related Contact Notes
Member Orientation Presentation 12/16/21
Naloxone (or other opioid antagonist) Statewide Standing Order for Registered Pharmacists
Naloxone (or other opioid antagonist) Standing Order Prescription Hardcopy
OMI Reportable Deaths on Death Certificates
Northwest Region Health Promotion Team